Cancer Research CANCER UK scientists have identified a brand new approach to cancer treatment which radically increases the effectiveness of radiotherapy, reveals a study published in Cancer Research on August 1
Scientists from the Cancer Research UK - MRC Gray Institute for Radiation Oncology & Biology at the University of Oxford - showed that treating mice with certain drugs improved the stability of blood vessels in the tumours.
Normally, these blood vessels are badly developed, weak and twisted and as a result cancer cells have lower oxygen levels than normal cells. But by improving the blood vessels the scientists increased the oxygen concentration inside the tumour - an effect that boosts tumours' sensitivity to radiotherapy. A better, more stable blood supply in the tumour also enables better delivery of chemotherapy drugs to the cancers.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze